
NASDAQ:BRCN • CA1208311029
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BURCON NUTRASCIENCE CORP (BRCN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2021-02-18 | Canaccord Genuity | Upgrade | |
| 2021-02-10 | Canaccord Genuity | Upgrade |
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 30K -25.00% | 260K 766.67% | 171.47K -34.05% | 1.082M 530.72% | 2.73M 152.38% | 6.625M 142.72% | 16.563M 150.00% | |
| EBITDA YoY % growth | -3.59M 15.73% | -4.46M -24.23% | -7.201M -61.45% | -6.798M 5.59% | -5.614M 17.42% | -4.599M 18.07% | -3.881M 15.61% | |
| EBIT YoY % growth | -3.63M 16.74% | -4.58M -26.17% | -7.357M -60.63% | N/A | N/A | N/A | N/A | |
| Operating Margin | -12,100.00% | -1,761.54% | -4,290.33% | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A 42.86% | N/A -150.00% | -0.10 -26.67% | -0.05 47.37% | -0.06 -7.14% | -0.06 -10.35% |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
11 analysts have analysed BRCN and the average price target is 1.67 USD. This implies a price increase of 279.09% is expected in the next year compared to the current price of 0.44.
BURCON NUTRASCIENCE CORP (BRCN) will report earnings on 2022-11-14.
The consensus rating for BURCON NUTRASCIENCE CORP (BRCN) is 85.4545 / 100 . This indicates that analysts generally have a positive outlook on the stock.